Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Acta Medica Iranica|December 31, 2016
Management of Retinal Vein Occlusion, Who Is Responsible?Mohamadreza Aghamirsalim, Reza Sorbi, Mohammadreza Naderian, et al.International Clinical Psychopharmacology|March 16, 2021
Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trialMostafa Farajollahi-Moghadam, Hossein Sanjari-Moghaddam, Maryam Ghazizadeh Hasemi, et al.Human Psychopharmacology|June 15, 2018
Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trialAlireza Ghajar, Faezeh Gholamian, Maryam Tabatabei-Motlagh, et al.International Clinical Psychopharmacology|May 24, 2021
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trialMaryam Masoudi, Sahar Ansari, Ladan Kashani, et al.Psychiatry Research|February 11, 2018
L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trialAlireza Ghajar, Mohammad-Reza Khoaie-Ardakani, Zahara Shahmoradi, et al.Journal of Affective Disorders|February 28, 2018
Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trialMaryam Ghazizadeh-Hashemi, Alireza Ghajar, Mohammad-Reza Shalbafan, et al.Psychiatry and Clinical Neurosciences|November 28, 2020
Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trialSaba Hoobehfekr, Hossein Sanjari Moghaddam, Mohammadreza Shalbafan, et al.Journal of Psychopharmacology (Oxford, England)|October 3, 2019
Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trialMohammadreza Shalbafan, Farzaneh Malekpour, Borna Tadayon Najafabadi, et al.Pageof 2